The medical aesthetics industry is booming as minimally invasive procedures gain mainstream acceptance and new clinics expand across the U.S. Major brands like Dermalogica are entering the market with FDA-cleared devices, while practitioners develop specialized treatments for emerging patient demographics including GLP-1 users.
·Market projected to hit $40.60 billion by 2031 driven by minimally invasive procedure demand
·New medical aesthetics clinics opening in multiple states including Arizona and Texas
·K-beauty inspired regenerative treatments like salmon DNA PDRN gaining traction
·Established skincare companies launching medical-grade devices to compete in aesthetics space
·Aesthetic practitioners tailoring care protocols for patients on weight-loss medications
drawn from CTPost, Barchart.com, PR Newswire, Queen Creek Tribune · updated 8h ago